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Abstract
Purpose: Hearing loss is the number one birth defect among children. There are significant consequences of delayed
diagnosis and failure to obtain timely intervention, particularly for a child’s speech and language development. Design and
implementation of successful newborn hearing screening (NHS) programs can be challenging. The purpose of this paper
is to demonstrate improved efficiency and effectiveness of a large NHS program through the implementation of a team
approach engaging both ambulatory and hospital services.
Methodology: A Strengths, Weaknesses, Opportunities, and Threats (SWOT) analysis was used to develop an improved
NHS program focused on improving patient care. The SWOT analysis outcomes were used to determine several key
factors to be implemented, including dedicated technicians solely assigned to the NHS program and purchase of new
equipment to improve accuracy and reduce disposable costs. In addition, a two-tiered approach was implemented
whereby the dedicated technicians performed initial screenings, with all rescreens performed by an audiologist.
Results: Implementation of the new NHS program demonstrated numerous successes including a significant reduction in
the failure rate, improved care coordination, and increased communication between ambulatory and hospital services.
Keywords: Newborn hearing screening, interdisciplinary collaboration, care coordination, congenital CMV
Acronyms: AABR = automated auditory brainstem response; ABR = auditory brainstem response; CMV =
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Between 1 and 3 of every 1000 live newborns are identified
as having congenital hearing loss, making it the most
common birth defect (Centers for Disease Control and
Prevention [CDC], 2018; Vohr, 2003). It is well established
that untreated hearing loss in the first few years of life
can have devastating consequences on a child’s speech
and language development. Hearing loss can also have
significant psychosocial and academic ramifications for
children (Tomblin et al., 2020; Wong et al., 2017). Key
to improving these outcomes is prompt diagnosis and
intervention to maximize early access to listening and

spoken language through hearing aids and cochlear
implants or to visual language via manual communication
(Sininger et al., 2010; Yoshinaga-Itano et al., 1998).
Universal Newborn Hearing Screening (NHS) is a vital
hospital program designed to ensure all infants with hearing
loss are quickly identified. NHS programs also provide a
framework for flagging infants at heightened risk for both
congenital and late onset hearing loss, so they may be
referred for more thorough testing and monitoring. This
includes infants with craniofacial malformations, certain
genetic syndromes, family history, in utero infections, other
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serious health conditions such as meningitis, and history
of medical treatments known to be associated with hearing
loss (Joint Committee on Infant Hearing [JCIH], 2019). At
notably increased risk are infants who receive care in the
neonatal intensive care unit (NICU), a population whose
rate of hearing loss has been reported as approximately
3% (Chang et al., 2020; Hille et al., 2007).

the program’s high rate of initial failures resulted in
inflated program cost and time investment. Screenings
were conducted by a large team of general medical
technicians who had numerous job responsibilities and
minimal NHS training. Limited program oversight and
poor interdepartmental communication left gaps in patient
care, particularly for infants with complex needs. Through
the implementation of a team approach engaging both
ambulatory and hospital services, the present project
aimed to improve the efficiency and effectiveness of the
UKMC NHS program.

National Early Hearing Detection and Intervention (EHDI)
guidelines from the JCIH (2019) state that all newborns
should be screened for hearing loss before age 1 month,
receive a diagnosis before age 3 months, and begin early
intervention before age 6 months. Meeting this critical “1-36” timeline is associated with improved language outcomes
for children with hearing loss and earlier activation of
cochlear implants in deaf children (Yoshinaga-Itano et al.,
2018). Although screening by age 1 month is the target,
the JCIH advocates it be completed prior to hospital
discharge. The recommended standard for newborns
referred for diagnostic assessment is less than 4% (JCIH,
2007). There are considerable challenges to developing
and implementing NHS programs to effectively meet these
goals. Obstacles may include financial, technological,
organizational, logistical, and human resource needs
(Winston-Gerson & Ditty, 2021).

Method
An interdisciplinary team was formed, including hospital
leadership and specialists from audiology, neonatology,
otolaryngology, and infectious disease. Additionally, the
chief of audiology was in communication with the Kentucky
EHDI Board regarding the program redesign. Collaborators
met over the course of a year to design and implement the
new NHS program, with the goal of reducing the screening
failure rate and improving overall patient care. A SWOT
(Strengths, Weaknesses, Opportunities, and Threats)
analysis was conducted. The results are outlined in Table
1. Based on the team’s discussion of the SWOT, it was
determined that the fundamental weaknesses affecting
screening rate and patient care were inadequate staffing,
older and inefficient equipment, and poor ambulatory/
hospital communication in cases of screening failure. To
address these weaknesses, a list of potential solutions
was generated. Cost versus benefit analysis of each
solution was discussed with regard to financial, time, and
human resource ramifications. Feedback from patient care
technicians, care team members, and families was taken
into consideration. It was ultimately decided that several
key changes would be enacted.

At the University of Kentucky Medical Center (UKMC)
2500 infants are screened for hearing loss every year on
average. All screenings are conducted prior to hospital
discharge, using automated auditory brainstem response
(AABR) equipment. UKMC does not conduct outpatient
rescreens after discharge, only full diagnostic auditory
brainstem response (ABR) evaluations. Screening
failure rate in the 2017–2018 fiscal year was 18% for
initial screens and 5% for repeat screens. In addition to
exceeding the limit of the national failure benchmark,

Table 1
SWOT Analysis of Pre-Existing Newborn Hearing Screening (NHS) Program
Strengths
•
•
•
•

Weaknesses

Large program with low rate of missed
screenings
Audiology department with nine licensed
audiologists on site
Access to large medical center resources
such as patient care coordinators, social
workers, etc.
Support from leadership for programmatic
improvements

•
•
•
•
•
•
•

High screening failure rate compared to national standard
High rate of missed diagnostic audiology follow-up
appointments
Poor communication between medical services for newborn
nursery and complex NICU patients
Disconnect between hospital and ambulatory care
Inadequate staffing for screenings
Lack of screening technicians with appropriate training and
experience
High cost of disposable materials

Opportunities
•
•
•
•
•

Interdepartmental collaboration
Advance technology and medicine
Meet or exceed national screening
guidelines
Improve patient care
Decrease loss to follow-up

Threats
•
•
•

Pressure to reduce costs while maintaining high standard
of care
Time constraints of audiologists
Non-NHS responsibilities and time constraints of screening
technicians

Note. SWOT = Strengths, Weaknesses, Opportunities, and Threats.
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NHS program changes initiated with the 2018–2019 fiscal
year and were compared with the 2017–2018 fiscal year to
determine the impact of the program redesign on screening
failure rate. Pass/fail data were collected by the hearing
screening technicians and audiologists. Feedback regarding
care coordination and interdepartmental communication
was collected from providers, technicians, and families by
their respective interdisciplinary team members.
Results
In the 2018–2019 fiscal year a total of 2,386 newborns
received a newborn hearing screening at UKMC, including
1513 infants in the newborn nursery and 873 infants in the
NICU (Figure 2). Of those screened, 9% failed the initial
screening and 2% failed the second screening (Figure 3).
This demonstrates a substantial decrease in the rate of
failed screenings compared to the 2017–2018 fiscal year,
in both the nursery and NICU populations (Figure 4). New
NHS equipment achieved a disposable cost reduction
of $11 per screening, resulting in approximately $30,000
savings to UKMC.
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First, two medical technicians were hired as dedicated
hearing screeners who were solely responsible for
completing and documenting the screenings. They were
specially trained on EHDI principles, equipment use,
and troubleshooting. The program also purchased new
AABR screening equipment with improved accuracy and
significantly lower disposable cost. Lastly, a two-tiered
screening approach was implemented in which a newborn
who failed the initial screening was rescreened by an
audiologist from UKMC (see Figure 1). All babies who
failed the second screening were referred for a diagnostic
ABR evaluation in the outpatient audiology clinic. Babies
who passed the screening but had risk factors for delayed
onset or progressive hearing loss were referred for
audiologic monitoring as recommended by JCIH 2019
guidelines. Babies who passed with no risk factors were
discharged from audiology service.
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Under the new screening program, clinical audiologists
completed all NHS program rescreens prior to newborn
discharge. Audiologists were scheduled to take call
for the NHS program for one week at a time, on a
rotating schedule. They conducted screenings during
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administrative or unstructured periods to ensure no loss of
revenue-generating clinic time. The process was typically
completed in 30 minutes or less. Their responsibilities
included: scheduling the outpatient diagnostic ABR
appointment immediately upon second screening failure,
counseling parents on the failed screening results,
providing pretest instructions for the ABR appointment,
and communicating the screening results and appointment
dates with other key professionals involved in the infant’s
care. For infants in the newborn nursery this included an
infectious disease physician and NHS program director.
For infants in the NICU, a neonatology physician and
patient care coordinators were also informed.
A targeted congenital cytomegalovirus (CMV) infection
screening program was initiated for all infants in the
newborn nursery who failed the second hearing screening.
This policy change did not impact patients in the NICU,
as all newborns treated in this unit are screened for CMV
upon admission.
Discussion
The collaborative redesign of the NHS program has
yielded numerous successes in the areas of patient care,
care coordination, and value. A major improvement with
respect to patient care is the significant decrease in both
initial and secondary screening failures; both rates have
been reduced by approximately 50%. Ongoing analyses
indicate this improvement has been sustained even in the
face of the COVID-19 pandemic, during which the UKMS
NHS program has remained in full operation. The program
continues to exceed its goal of meeting the JCIH quality
benchmark of 4% or less of final referrals for diagnostic
audiological testing. Although superior technical accuracy
of the new AABR equipment cannot be overlooked,
it is suspected that strengthened program staffing
also plays a significant role in achieving this goal. The
quality of screenings improved by hiring two technicians
designated as hearing screeners, modifying their clinical
responsibilities to ensure adequate time for screenings,
and training them in principles of newborn hearing,
equipment use, and troubleshooting.
Introduction of experienced audiologists to the secondary
screening phase has also been essential to improving
patient care. The audiologists provide expertise in hearing
assessment and advanced equipment troubleshooting
as needed. Perhaps more importantly, they also provide
individualized counseling to families whose newborns
fail the rescreen. The focus of counseling was basic
principles of newborn hearing screening and diagnostic
testing, and pre-test instructions to support a successful
outpatient ABR. Informational counseling from a clinical
audiologist was included in the program redesign with the
hope of improving caregiver knowledge and reducing loss
to follow-up. UKMC is currently collecting and analyzing
loss to follow-up data to determine if the program changes
positively impacted loss to follow-up rates.
Another success of the redesigned NHS program is
improved care coordination and communication between
ambulatory and hospital services. Ensuring proper time

for conducting and communicating results of a hearing
screen can be challenging amidst a newborn’s many
initial evaluations. This is particularly true for medically
fragile babies who require lengthy hospital admissions
and for whom hearing screening is not a priority. Typical
communication and planning channels can also be
interrupted by instability of a newborn’s social situation,
such as changes in custody or foster care. Deploying
UKMC’s audiologists as hearing care coordinators seeks
to overcome these challenges. Immediately scheduling
outpatient appointments, communicating results with
families, and directly contacting medical team members
ensures all stakeholders are informed of needed follow-up.
Appointments can be scheduled on a timeline sensitive
to the caregivers’ logistical needs, which is another factor
believed to play a significant role in loss to follow-up (Ravi et
al., 2016). Designation of an NHS program director has also
proven essential to care coordination and communication.
The program director serves as a chief point of contact
between hospital and ambulatory services, coordinates any
emergent testing needs (e.g., congenital CMV or meningitis),
oversees program implementation and statistic tracking, and
resolves any programmatic issues or concerns that arise.
Lastly, NHS program changes have achieved significant
time and financial savings to UKMC. The use of dedicated
hearing screeners has allowed nursery and NICU directors
to redeploy non-screening technicians to their primary job
duties. Experienced screeners using new equipment with
greater accuracy has greatly reduced the number of repeat
screenings required, cutting both physical costs and time
investment. The new equipment also requires significantly
less disposable costs, at only $2.50 per screening. The
original AABR equipment required nearly $14 in supplies
per screening. Taking into account both initial screenings
and rescreens, it is estimated that this substantial cost
reduction has saved UKMC approximately $30,000 annually
since the changes were implemented. Such savings have
more than accounted for the initial cost of new equipment.
An unanticipated outcome of the program redesign has
been development of a targeted CMV screening policy in
the newborn nursery. CMV is the most common congenital
viral infection in the United States, affecting approximately
1 in 200 newborns (CDC, 2020). It can result in significant
central nervous system deficits, including congenital and
delayed onset hearing loss. Early diagnosis allows for
swift initiation of antiviral therapy, which may improve
hearing outcomes in some affected newborns (CDC,
2020). Additionally, early diagnosis allows for initiation
of close audiologic monitoring during a child’s critical
developmental years. This new collaborative screening
policy elevates the standard of care provided to newborns
at UKMC, in addition to bolstering interdisciplinary team
involvement in the NHS program. It is the authors’ hope
that early identification of both congenital CMV infection
and hearing loss will result in earlier involvement of other
critical medical specialties and intervention services.
Future directions for this project will include outcome
measures beyond hospital screenings, to see if successes
in this phase do in fact result in lowered age of hearing loss

The Journal of Early Hearing Detection and Intervention 2022: 7(1)

40

diagnosis and initiation of intervention at UKMC. Also of
interest is probing the efficiency of the program’s diagnostic
phase, through measures such as outpatient ABR no-show
rates and number of appointments required to obtain a
diagnosis. Additionally, after the successful establishment
of a working relationship between audiology and infectious
disease, the authors are looking to expand partnerships
with other key services to develop standardized hearing
care paths for infants at higher risk of hearing loss.
Conclusion
The NHS program at UKMC was collaboratively
redesigned using results from a SWOT analysis completed
by a multidisciplinary team. Key changes included
designating two medical technicians as the sole hearing
screeners, purchasing new equipment with improved
technical accuracy and lower disposable costs, and
implementing a two-tiered screening protocol by which
audiologists completed all repeat screenings and provided
information counseling and hearing care coordination.
These changes resulted in decreased screening failure
rates, increased communication between hospital
and ambulatory services, improved care coordination,
significant cost savings, and a new targeted CMV
screening protocol in the newborn nursery.
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